First step toward gene therapy for rare anemia: can stem cells be harvested?

This study checks if people with Diamond Blackfan Anemia (ages 3-30) can produce enough blood stem cells for future gene therapy. Participants receive two drugs to move stem cells from bone marrow into the blood, then researchers measure the cell count. No actual stem cell collection is done—this is a feasibility test to see if enough cells can be mobilized.